Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1992 Jun;30(6):1617–1619. doi: 10.1128/jcm.30.6.1617-1619.1992

Stability of the recombinant hepatitis B core antigen.

N Nath 1, K Hickman 1, S Nowlan 1, D Shah 1, J Phillips 1, S Babler 1
PMCID: PMC265347  PMID: 1624588

Abstract

The recombinant gene for hepatitis B core antigen (HBcAg) was cloned and expressed, and the protein was purified from Escherichia coli cultures. Purified HBcAg was tested for the effects of various physical and chemical agents on its immunoreactivity by a paramagnetic particle-based enzyme immunoassay. Recombinant HBcAg retained its immunoreactivity when heated at 70 degrees C for 60 min but was inactivated at 85 degrees C in 10 min. It was stable between pHs 5 and 10.5 but not at pHs 2 and 13.5. Treatment with sodium dodecyl sulfate (SDS), ethanol, and methanol caused a significant loss in HBcAg reactivity. The proteolytic enzymes papain and bacterial protease (type VIII from Bacillus licheniformis) degraded HBcAg significantly, but trypsin and chymotrypsin did not. The effect of combined SDS and 2-mercaptoethanol on recombinant HBcAg was an immediate loss in immunoreactivity, followed by rapid recovery to about 50% of the initial level. This level was maintained for 24 to 48 h and was followed by an almost total loss of HBcAg in about 120 h.

Full text

PDF
1617

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Budkowska A. Immunochemical and morphological studies of hepatitis B core antigen isolated from the nuclei of hepatocytes. J Infect Dis. 1977 Mar;135(3):463–467. doi: 10.1093/infdis/135.3.463. [DOI] [PubMed] [Google Scholar]
  2. Hoofnagle J. H., Gerety R. J., Barker L. F. Antibody to hepatitis-B-virus core in man. Lancet. 1973 Oct 20;2(7834):869–873. doi: 10.1016/s0140-6736(73)92004-7. [DOI] [PubMed] [Google Scholar]
  3. Koziol D. E., Holland P. V., Alling D. W., Melpolder J. C., Solomon R. E., Purcell R. H., Hudson L. M., Shoup F. J., Krakauer H., Alter H. J. Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. Ann Intern Med. 1986 Apr;104(4):488–495. doi: 10.7326/0003-4819-104-4-488. [DOI] [PubMed] [Google Scholar]
  4. MacKay P., Lees J., Murray K. The conversion of hepatitis B core antigen synthesized in E coli into e antigen. J Med Virol. 1981;8(4):237–243. doi: 10.1002/jmv.1890080404. [DOI] [PubMed] [Google Scholar]
  5. Miyanohara A., Imamura T., Araki M., Sugawara K., Ohtomo N., Matsubara K. Expression of hepatitis B virus core antigen gene in Saccharomyces cerevisiae: synthesis of two polypeptides translated from different initiation codons. J Virol. 1986 Jul;59(1):176–180. doi: 10.1128/jvi.59.1.176-180.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Möller B., Hopf U., Stemerowicz R., Henze G., Gelderblom H. HBcAg expressed on the surface of circulating Dane particles in patients with hepatitis B virus infection without evidence of anti-HBc formation. Hepatology. 1989 Aug;10(2):179–185. doi: 10.1002/hep.1840100210. [DOI] [PubMed] [Google Scholar]
  7. Ohori H., Shimizu N., Yamada E., Onodera S., Ishida N. Immunological and morphological properties of HBeAg subtypes (HBeAg/1 and HBeAg/2) in hepatitis B virus core particles. J Gen Virol. 1984 Feb;65(Pt 2):405–414. doi: 10.1099/0022-1317-65-2-405. [DOI] [PubMed] [Google Scholar]
  8. Ohori H., Yamaki M., Onodera S., Yamada E., Ishida N. Antigenic conversion from HBcAg to HBeAg by degradation of hepatitis B core particles. Intervirology. 1980;13(2):74–82. doi: 10.1159/000149110. [DOI] [PubMed] [Google Scholar]
  9. Pasek M., Goto T., Gilbert W., Zink B., Schaller H., MacKay P., Leadbetter G., Murray K. Hepatitis B virus genes and their expression in E. coli. Nature. 1979 Dec 6;282(5739):575–579. doi: 10.1038/282575a0. [DOI] [PubMed] [Google Scholar]
  10. Stahl S., MacKay P., Magazin M., Bruce S. A., Murray K. Hepatitis B virus core antigen: synthesis in Escherichia coli and application in diagnosis. Proc Natl Acad Sci U S A. 1982 Mar;79(5):1606–1610. doi: 10.1073/pnas.79.5.1606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Waters J. A., Jowett T. P., Thomas H. C. Identification of a dominant immunogenic epitope of the nucleocapsid (HBc) of the hepatitis B virus. J Med Virol. 1986 May;19(1):79–86. doi: 10.1002/jmv.1890190112. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES